Syngene International Revenue

Syngene International had revenue of 9.44B INR in the quarter ending December 31, 2024, with 10.57% growth. This brings the company's revenue in the last twelve months to 35.41B, down -0.70% year-over-year. In the fiscal year ending March 31, 2024, Syngene International had annual revenue of 34.89B with 9.26% growth.

Revenue (ttm)

35.41B

Revenue Growth

-0.70%

P/S Ratio

9.61

Revenue / Employee

5.44M

Employees

6,510

Market Cap

339.88B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	34.89B	2.96B	9.26%
Mar 31, 2023	31.93B	5.89B	22.61%
Mar 31, 2022	26.04B	4.20B	19.22%
Mar 31, 2021	21.84B	1.72B	8.57%
Mar 31, 2020	20.12B	1.86B	10.20%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	503.08B
Divi's Laboratories	86.14B
Cipla	262.64B
Mankind Pharma	110.18B
Apollo Hospitals Enterprise	204.69B
Zydus Lifesciences	214.84B
Aurobindo Pharma	302.95B
Alkem Laboratories	128.32B

Revenue Rankings

Syngene International News

6 weeks ago - Syngene shares surge after 2% equity worth Rs 706 crore changes hands in block deal - Business Upturn
2 months ago - Syngene International’s market cap decreases by Rs 760 crore as shares drop 2.19% today – Know More - Business Upturn

More News